Depressive symptoms, HIV medication adherence, and HIV clinical outcomes in Tanzania: A prospective, observational study

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Belenky, Nadya M ^a   Cole, Stephen R ^a   Pence, Brian W ^a,b   Itemba, Dafrosa ^c   Maro, Venance ^d   Whetten, Kathryn ^b  

^a University of North Carolina at Chapel Hill   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Tanzania Women Research Foundation   (Tanzania)

^d KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CD4 LYMPHOCYTE COUNT; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PROSPECTIVE STUDY; TANZANIA; TREATMENT OUTCOME; VIROLOGIC FAILURE; ACQUIRED IMMUNODEFICIENCY SYNDROME; CLINICAL TRIAL; MIDDLE AGED;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; DEPRESSION; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROSPECTIVE STUDIES; TANZANIA;

EID: 84900391770     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095469     Document Type: Article

References (25)

1. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, et al. (1997) A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. New England Journal of Medicine 337: 725-733. (Pubitemid 27417971)
2. Hammer SM, Eron JJ, Reiss P, Schooley RT, Thompson MA, et al. (2008) Antiretroviral treatment of adult HIV infection. JAMA: The Journal of the American Medical Association 300: 555.
3. Schneider MF, Gange SJ, Williams CM, Anastos K, Greenblatt RM, et al. (2005) Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. Aids 19: 2009.
4. Leserman J, Jackson ED, Petitto JM, Golden RN, Silva SG, et al. (1999) Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosomatic Medicine 61: 397.
5. Antelman G, Kaaya S, Wei R, Mbwambo J, Msamanga GI, et al. (2007) Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J Acquir Immune Defic Syndr 44: 470-477. (Pubitemid 46555384)
6. Rao D, Feldman BJ, Fredericksen RJ, Crane PK, Simoni JM, et al. (2012) A structural equation model of HIV-related stigma, depressive symptoms, and medication adherence. AIDS and Behavior 16: 711-716.
7. Wilson TE, Barrón Y, Cohen M, Richardson J, Greenblatt R, et al. (2002) Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clinical Infectious Diseases 34: 529-534. (Pubitemid 34112276)
8. Ironson G, O'Cleirigh C, Fletcher MA, Laurenceau JP, Balbin E, et al. (2005) Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosomatic Medicine 67: 1013-1021. (Pubitemid 43740117)
9. World Health Organization (2005) Mental Health Atlas. Geneva: World Health Organization.
10. Saxena S, Sharan P, Garrido M, Saraceno B (2006) World Health Organization's mental health atlas 2005: implications for policy development. World Psychiatry 5: 179.
11. Evans D, Leserman J, Pedersen C, Golden R, Lewis M, et al. (1989) Immune correlates of stress and depression. Psychopharmacology bulletin 25: 319.
12. Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, et al. (2005) Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther 10: 53-61. (Pubitemid 40767631)
13. Anastos K, Schneider MF, Gange SJ, Minkoff H, Greenblatt RM, et al. (2005) The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women. Journal of Acquired Immune Deficiency Syndromes 39: 537.
14. Cook JA, Grey D, Burke J, Cohen MH, Gurtman AC, et al. (2004) Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. American Journal of Public Health 94: 1133.
15. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, et al. (2001) Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 285: 1466-1474. (Pubitemid 32221895)
16. Leserman J, Pence BW, Whetten K, Mugavero MJ, Thielman NM, et al. (2007) Relation of lifetime trauma and depressive symptoms to mortality in HIV. The American journal of psychiatry.
17. Ickovics JR, Meade CS (2002) Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences. Journal of Acquired Immune Deficiency Syndromes 31: S98.
18. Gonzalez JS, Batchelder AW, Psaros C, Safren SA (2011) Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes 58: 181.
19. Nakimuli-Mpungu E, Bass JK, Alexandre P, Mills EJ, Musisi S, et al. (2012) Depression, alcohol use and adherence to antiretroviral therapy in Sub-Saharan Africa: a systematic review. AIDS and Behavior 16: 2101-2118.
20. Pence BW, Shirey K, Whetten K, Agala B, Itemba D, et al. (2012) Prevalence of Psychological Trauma and Association with Current Health and Functioning in a Sample of HIV-infected and HIV-uninfected Tanzanian Adults. PloS one 7: 1932-6203.
21. Kroenke K, Spitzer RL, Williams JBW (2001) The PHQ-9. Journal of General Internal Medicine 16: 606-613.
22. Spitzer RL, Kroenke K, Williams JBW (1999) Validation and utility of a self-report version of PRIME-MD. JAMA 282: 1737-1744. (Pubitemid 29533604)
23. Adewuya AO, Ola BA, Afolabi OO (2006) Validity of the patient health questionnaire (PHQ-9) as a screening tool for depression amongst Nigerian university students. Journal of Affective Disorders 96: 89-93. (Pubitemid 44548051)
24. Monahan PO, Shacham E, Reece M, Kroenke K, Ong'or WO, et al. (2009) Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in western Kenya. Journal of General Internal Medicine 24: 189-197.
25. Liu H, Miller LG, Hays RD, Golin CE, Wu T, et al. (2006) Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. Journal of Acquired Immune Deficiency Syndromes 41: 315-322.